Subscribe to our Newsletters !!
In tortoises, longevity is an astonishing trait. N
With today’s scientific landscape, laboratories
Dr. Mohammed Enayat’s recent testimony on his ag
This year, the Hamburg based life sciences company
Cipla Limited (BSE: 5
Since it’s an ingredient in so many foods, you h
Welcome to the latest issue of Microbioz India. As
Dr. Hemant R. Jadhav, a BITS Pilani professor, spends his days sketching tiny drug-like shapes on a computer screen and nights watching them grow into real compounds. His work targets cancer, HIV, Alzheimer’s, and diabetes—blending molecular design with hands-on testing to yield future-ready therapies.
At the core of his research are histone demethylases—epigenetic gatekeepers that control disease expression like a lock-and-key system. By combining in-silico predictions with experimental pharmacology, Dr. Jadhav is accelerating the drug discovery timeline.
Despite challenges in solubility, selectivity, and scalability, his multidisciplinary approach paves the way for smarter, more effective treatments.
Come prepared to think differently. This isn’t your usual lecture. Dr. Jadhav’s sharp insights make this a can’t-miss session—especially if you’re invested in the future of precision medicine.
